Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:46 am
Author: Getaka|Social: XLinkedIn

Syngene International Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹387.81Fairly Valued by 2.07%vs CMP ₹396.00

P/E (39.0) × ROE (10.5%) × BV (₹118.00) × DY (0.32%)

₹198.65Overvalued by 49.84%vs CMP ₹396.00
MoS: -99.3% (Negative)Confidence: 58/100 (Moderate)Models: 2 Fair, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹378.4122%Fair (-4.4%)
Graham NumberEarnings₹152.3316%Over (-61.5%)
Earnings PowerEarnings₹87.4213%Over (-77.9%)
DCFCash Flow₹76.5613%Over (-80.7%)
Net Asset ValueAssets₹117.397%Over (-70.4%)
EV/EBITDAEnterprise₹425.289%Fair (+7.4%)
Earnings YieldEarnings₹87.407%Over (-77.9%)
ROCE CapitalReturns₹135.227%Over (-65.9%)
Revenue MultipleRevenue₹135.445%Over (-65.8%)
Consensus (9 models)₹198.65100%Overvalued
Key Drivers: Wide model spread (₹77–₹425) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -2.4%

*Investments are subject to market risks

Investment Snapshot

60
Syngene International Ltd scores 60/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health76/100 · Strong
ROCE 13.5% GoodROE 10.5% AverageD/E 0.27 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding down -4.51% (6mo) SellingDII holding up 4.33% MF buyingPromoter holding at 52.7% Stable
Earnings Quality60/100 · Moderate
OPM stable around 29% SteadyWorking capital: -51 days (improving) Efficient
Quarterly Momentum40/100 · Moderate
Revenue (4Q): +5% YoY GrowingProfit (4Q): -30% YoY DecliningOPM: 23.0% (down 7.0% YoY) Margin pressure
Industry Rank65/100 · Strong
P/E 39.0 vs industry 271.4 Cheaper than peersROCE 13.5% vs industry 48.4% Below peersROE 10.5% vs industry 7.4% Above peers3Y sales CAGR: 12% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Syngene International Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
40/100
Moderate
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 39.0 vs Ind 271.4 | ROCE 13.5% | ROE 10.5% | CFO/NP N/A
Balance Sheet Stress
0/100
Comfortable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.27x | IntCov 0.0x | Current 1.59x | Borrow/Reserve 0.13x
Cash Flow Reliability
43/100
Mixed
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹496 Cr | CFO/NP N/A
Ownership Accumulation
0
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII -1.35 pp | DII +1.21 pp | Prom 0.00 pp
Business Momentum
-88
Watch closely
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales +0.7% | Q NP -77.6% | Q OPM +1.0 pp
Derived FieldValueHow it is derived
Valuation Gap %-49.8%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.13xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII Change-1.35 ppLatest FII% minus previous FII%
DII Change+1.21 ppLatest DII% minus previous DII%
Promoter Change0.00 ppLatest promoter% minus previous promoter%
Shareholder Count Change-4,311Latest shareholder count minus previous count
Quarterly Sales Change+0.7%Latest quarter sales vs previous quarter sales
Quarterly Profit Change-77.6%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change+1.0 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:46 am

Market Cap 15,973 Cr.
Current Price 396
Intrinsic Value₹198.65
High / Low 761/381
Stock P/E39.0
Book Value 118
Dividend Yield0.32 %
ROCE13.5 %
ROE10.5 %
Face Value 10.0
PEG Ratio-16.10

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Syngene International Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Syngene International Ltd 15,973 Cr. 396 761/38139.0 1180.32 %13.5 %10.5 % 10.0
Sun Pharma Advanced Research Company Ltd 3,905 Cr. 120 204/108 10.80.00 %298 %% 1.00
Dredging Corporation of India Ltd 2,322 Cr. 829 1,246/495 4050.00 %0.31 %3.67 % 10.0
Logica Infoway Ltd 322 Cr. 181 267/16323.5 53.00.00 %14.3 %14.1 % 10.0
FGP Ltd 12.4 Cr. 10.4 13.7/7.3259.0 3.090.00 %0.00 %0.89 % 10.0
Industry Average5,630.50 Cr219.61271.38103.340.05%48.42%7.44%9.00

All Competitor Stocks of Syngene International Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 7869948089108549177908919441,018874911917
Expenses 555680596656622600620646660674668711708
Operating Profit 231314212254232317170245284344206200209
OPM % 29%32%26%28%27%35%22%27%30%34%24%22%23%
Other Income 172324142616501618191815-55
Interest 14101013111312131216121312
Depreciation 9596102105108111107111109106111116114
Profit before tax 1402311231511382091011371812401018528
Tax % 22%23%24%23%19%10%25%23%27%24%14%21%47%
Net Profit 1101799311611218976106131183876715
EPS in Rs 2.734.452.322.902.774.691.882.643.264.552.151.670.37

Last Updated: February 3, 2026, 11:46 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 1:51 am

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,4231,8262,0122,1842,6043,1933,4893,6423,720
Expenses 9491,2891,3941,5071,8062,2512,4722,5982,762
Operating Profit 4745376186787989421,0171,045959
OPM % 33%29%31%31%31%30%29%29%26%
Other Income 537515394206377101-3
Interest 233235282445475353
Depreciation 131164219274310366426433448
Profit before tax 372415517469484594621660455
Tax % 18%20%20%14%18%22%18%25%
Net Profit 305332412405396464510496352
EPS in Rs 7.648.2910.3010.129.8811.5712.6912.338.74
Dividend Payout % 7%3%0%0%10%11%10%10%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)8.85%24.10%-1.70%-2.22%17.17%9.91%-2.75%
Change in YoY Net Profit Growth (%)0.00%15.24%-25.80%-0.52%19.39%-7.26%-12.66%

Syngene International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:13%
3 Years:12%
TTM:7%
Compounded Profit Growth
10 Years:%
5 Years:6%
3 Years:4%
TTM:6%
Stock Price CAGR
10 Years:15%
5 Years:7%
3 Years:5%
1 Year:-28%
Return on Equity
10 Years:%
5 Years:13%
3 Years:12%
Last Year:11%

Last Updated: September 5, 2025, 1:41 pm

Balance Sheet

Last Updated: December 4, 2025, 2:04 am

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 200200400400401401402402403
Reserves 1,5201,7681,7762,4212,8973,2173,8564,3244,332
Borrowings 7878137738931,022815555578582
Other Liabilities 6819221,2141,1691,2451,3981,3391,4911,226
Total Liabilities 3,1893,7044,1634,8835,5645,8316,1526,7966,542
Fixed Assets 1,0301,3772,0202,2012,3932,6672,8502,8023,049
CWIP 1552742342373461778381,266989
Investments 1587167767021,034918548647547
Other Assets 1,8461,3371,1331,7431,7902,0691,9162,0811,957
Total Assets 3,1893,7044,1634,8835,5645,8316,1526,7966,542

Reserves and Borrowings Chart

Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 4466306777015818241,0421,168
Cash from Investing Activity + -349-646-424-629-611-653-494-744
Cash from Financing Activity + -79-72-22658-31-342-552-142
Net Cash Flow 18-8828130-62-172-4281
Free Cash Flow 824734255105305553398
CFO/OP 111%135%127%116%92%102%115%123%

Free Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-313.00-276.00-155.00-215.00797.00127.00-554.00-577.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 6868727971614653
Inventory Days 82301841871419460
Days Payable 195154156167113109100136
Cash Conversion Cycle -44-56-66-47459240-23
Working Capital Days -48-103-172-66-43-14-27-51
ROCE %17%17%14%13%15%15%14%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 54.88%54.80%54.79%54.79%54.79%54.72%54.72%52.74%52.74%52.68%52.68%52.68%
FIIs 23.31%23.19%23.55%21.20%20.92%20.64%20.72%20.65%19.47%16.51%16.31%14.96%
DIIs 10.71%11.20%11.70%14.63%15.80%16.78%17.49%19.52%21.50%24.05%24.62%25.83%
Public 10.65%10.23%9.47%9.07%8.18%7.44%6.74%6.79%5.99%6.45%6.08%6.22%
Others 0.46%0.60%0.48%0.32%0.31%0.43%0.34%0.29%0.29%0.31%0.30%0.29%
No. of Shareholders 1,24,0141,25,4551,25,9921,21,8801,15,8501,20,0181,07,3381,28,8061,25,0901,42,3101,36,0611,31,750

Shareholding Pattern Chart

No. of Shareholders

Syngene International Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund 6,952,323 0.43 293.535,356,3262026-03-23 04:57:4629.8%
Nippon India Focused Fund 5,746,009 2.86 242.64,983,1772026-03-23 04:24:3015.31%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 5,096,498 3.16 215.174,205,5282026-03-23 07:11:2221.19%
Nippon India Multi Cap Fund 4,621,925 0.38 195.14N/AN/AN/A
Mirae Asset Focused Fund 4,207,261 2.53 177.634,326,5122026-01-26 00:59:00-2.76%
Mirae Asset Large & Midcap Fund 4,006,393 0.39 169.155,189,8542026-03-24 01:55:36-22.8%
DSP ELSS Tax Saver Fund 3,903,263 0.96 164.83,737,9832026-02-21 03:46:044.42%
ICICI Prudential Multicap Fund 3,773,806 0.98 159.333,273,8062026-03-24 00:33:1915.27%
ICICI Prudential ELSS Tax Saver Fund 3,770,138 1.11 159.183,400,2672025-12-08 06:31:0410.88%
DSP Large & Mid Cap Fund 3,535,665 0.85 149.283,369,9702026-02-21 03:46:044.92%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 12.3512.7111.599.9410.18
Diluted EPS (Rs.) 12.3412.6911.519.8210.11
Cash EPS (Rs.) 23.0723.2820.7017.6016.98
Book Value[Excl.RevalReserv]/Share (Rs.) 117.44105.9290.1382.2870.53
Book Value[Incl.RevalReserv]/Share (Rs.) 117.44105.9290.1382.2870.53
Revenue From Operations / Share (Rs.) 90.4986.7879.5464.9754.61
PBDIT / Share (Rs.) 27.6727.4925.0421.1818.41
PBIT / Share (Rs.) 16.9216.8915.9113.4511.55
PBT / Share (Rs.) 16.4015.4414.7912.0911.73
Net Profit / Share (Rs.) 12.3312.6911.579.8810.12
NP After MI And SOA / Share (Rs.) 12.3312.6911.579.8810.12
PBDIT Margin (%) 30.5731.6731.4832.5933.71
PBIT Margin (%) 18.6919.4620.0020.7021.14
PBT Margin (%) 18.1117.7918.5918.6021.48
Net Profit Margin (%) 13.6214.6114.5415.1918.53
NP After MI And SOA Margin (%) 13.6214.6114.5415.1918.53
Return on Networth / Equity (%) 10.4911.9712.8312.0014.35
Return on Capital Employeed (%) 12.6113.5613.7512.4312.31
Return On Assets (%) 7.308.297.967.118.29
Long Term Debt / Equity (X) 0.000.020.130.160.18
Total Debt / Equity (X) 0.020.030.150.230.27
Asset Turnover Ratio (%) 0.560.580.550.490.48
Current Ratio (X) 1.641.712.041.791.59
Quick Ratio (X) 1.531.501.761.651.54
Inventory Turnover Ratio (X) 18.493.063.526.4513.01
Dividend Payout Ratio (NP) (%) 10.139.868.630.000.00
Dividend Payout Ratio (CP) (%) 5.415.374.820.000.00
Earning Retention Ratio (%) 89.8790.1491.370.000.00
Cash Earning Retention Ratio (%) 94.5994.6395.180.000.00
Interest Coverage Ratio (X) 20.9723.4122.2435.2226.58
Interest Coverage Ratio (Post Tax) (X) 9.7412.0411.2718.7014.35
Enterprise Value (Cr.) 28558.1327786.5423908.8424195.4521863.70
EV / Net Operating Revenue (X) 7.847.967.499.2910.01
EV / EBITDA (X) 25.6425.1523.7828.5029.69
MarketCap / Net Operating Revenue (X) 8.028.097.479.199.95
Retention Ratios (%) 89.8690.1391.360.000.00
Price / BV (X) 6.186.636.607.257.70
Price / Net Operating Revenue (X) 8.028.097.479.199.95
EarningsYield 0.010.010.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937. Currently Company is involved in the business activities of Scientific research and development. Company's Total Operating Revenue is Rs. 3373.30 Cr. and Equity Capital is Rs. 402.50 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsBiocon SEZ, Biocon Park, Bengaluru Karnataka 560099Contact not found
Management
NamePosition Held
Ms. Kiran Mazumdar ShawNon Executive Chairman
Mr. Peter BainsManaging Director & CEO
Prof. Catherine RosenbergNon Executive Director
Ms. Vinita BaliLead Independent Director
Mr. Nilanjan RoyIndependent Director
Dr. Kush ParmarIndependent Director
Ms. Sharmila Abhay KarveIndependent Director
Dr. Vijay KuchrooIndependent Director
Mr. Manja BoermanIndependent Director

FAQ

What is the intrinsic value of Syngene International Ltd and is it undervalued?

As of 05 April 2026, Syngene International Ltd's intrinsic value is ₹198.65, which is 49.84% lower than the current market price of ₹396.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (10.5 %), book value (₹118), dividend yield (0.32 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Syngene International Ltd?

Syngene International Ltd is trading at ₹396.00 as of 05 April 2026, with a FY2026-2027 high of ₹761 and low of ₹381. The stock is currently near its 52-week low. Market cap stands at ₹15,973 Cr..

How does Syngene International Ltd's P/E ratio compare to its industry?

Syngene International Ltd has a P/E ratio of 39.0, which is below the industry average of 271.38. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Syngene International Ltd financially healthy?

Key indicators for Syngene International Ltd: ROCE of 13.5 % is moderate. Dividend yield is 0.32 %.

Is Syngene International Ltd profitable and how is the profit trend?

Syngene International Ltd reported a net profit of ₹496 Cr in Mar 2025 on revenue of ₹3,642 Cr. Compared to ₹396 Cr in Mar 2022, the net profit shows an improving trend.

Does Syngene International Ltd pay dividends?

Syngene International Ltd has a dividend yield of 0.32 % at the current price of ₹396.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Syngene International Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports